Clinical Trial Update: Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cadonilimab in combination with stereotactic radiotherapy as a second-line treatment for brain metastases in non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Rongrong Zhou | Conditions: Non Small Cell Lung Cancer, Brain Metastases | Phase 2 | Status: RECRUITING